URDU TRANSLATION, VALIDITY & RELIABILITY OF LEADS ASSESSMENT OF NEUROPATHIC SYMPTOMS AND SIGN PAIN SCALE (LANSS) QUESTIONNAIRE

Main Article Content

Dr. Saman Jahangir
Dr. Humera Ayub
Dr. Ahmed Sadiq Sheikh
Abdul Moiz khan
Dr Sidra Tariq
Dr. Muhammad Saad Shafique
Navera Salahuddin
Dr. Hina Hazrat

Keywords

Douleur neuropathic 4 questionnaires (DN4), Leads assessment of neuropathic symptoms and signs pain scale (LANSS), Barthel index, visual analog scale, neuropathic pain

Abstract

Background: 


The LANSS questionnaire is used for the assessment of neuropathic pain and examination of functional outcomes of the physical therapy treatment following neuropathic pain. This questionnaire exhibited significant characteristics as an assessment for patients with neuropathic pain. 


Objective: 


To translate the Leads Assessment of Neuropathic Symptoms and Signs Pain Scale (LANSS) in Urdu and determine its Validity & reliability through characteristic properties.


Methodology: 


In this descriptive cross-sectional study, a non-probability purposive sampling technique was used to assess 70 neuropathic patients for the LANSS questionnaire. The Participants were asked to fill out the Leads Assessment of Neuropathic Symptoms and Signs Pain Scale (LANSS) and Douleur Neuropathic 4 Questionnaire (DN4), VAS, Barthel index. The data was collected on the first clinical day and the second and third follow-up days.


Results:


The results revealed that the test-retest reliability for LANSS is sustainable. The overall outcome depicts that the reliability coefficient for LANSS (ICC=0.83, CI= 95%) is good.


Conclusion


The Urdu-translated version of LANSS is valid and reliable for the assessment and evaluation of neurological symptoms in clinical examination.

Abstract 184 | pdf Downloads 25

References

Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: from mechanisms to treatment. Physiological reviews. 2021;101(1):259-301.
2. Moisset X, Bouhassira D, Couturier JA, Alchaar H, Conradi S, Delmotte M, et al. Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations. Revue Neurologique. 2020;176(5):325-52.
3. Feldman E, Callaghan B, Pop-Busui R, Zochodne D, Wright D, Bennett D, et al. Diabetic neuropathy. Nature reviews. Disease primers, 5 (1), 41. 2019.
4. Akram MJ, Malik AN. Frequency of chronic neuropathic pain and its association with depression in the elderly in Pakistan. J Pak Med Assoc. 2019;69:1907-9.
5. Bonhof CS, van de Poll-Franse LV, Wasowicz DK, Beerepoot LV, Vreugdenhil G, Mols F. The course of peripheral neuropathy and its association with health-related quality of life among colorectal cancer patients. Journal of Cancer Survivorship. 2021;15(2):190-200.
6. Dunker Ø, Grotle M, Kvaløy MB, Uglem M, Løseth S, Hjelland IE, et al. Accuracy of neuropathic pain measurements in patients with symptoms of polyneuropathy: validation of painDETECT, S-LANSS, and DN4. Pain. 2022:10.1097.
7. Hepşen S, Keskin DB, Çakal E. The assessment of neuropathic pain in patients with prediabetes. Primary Care Diabetes. 2022.
8. Gladović N, Leško L, Fudurić M. Effectiveness of manual yumeiho therapy and exercise on depression and neuropathic pain in patients suffering from chronic nonspecific low back pain. Sport and Quality of Life 7–9 11 2019. 2020:211.
9. dos Santos Barros V, Bassi-Dibai D, Guedes CLR, Morais DN, Coutinho SM, de Oliveira Simões G, et al. Barthel Index is a valid and reliable tool to measure the functional independence of cancer patients in palliative care. BMC Palliative Care. 2022;21(1):1-7.
10. Modarresi S, Lukacs MJ, Ghodrati M, Salim S, MacDermid JC, Walton DM. A Systematic Review and Synthesis of Psychometric Properties of the Numeric Pain Rating Scale and the Visual Analog Scale for Use in People With Neck Pain. The Clinical Journal of Pain. 2022;38(2):132-48.
11. Fagbohun T. SYSTEMATIC REVIEW ON THE PSYCHOMETRIC, RELIABILITY AND VALIDITY PROPERTIES OF TRANSLATED NEUROPATHIC PAIN SCREENING TOOLS (DN4, LANSS AND PDQ) 1 JANUARY 2005–19 JULY 2019. International Journal of Medicine and Medical Research. 2021;7(1):51-67.
12. Gierthmühlen J, Schneider U, Seemann M, Freitag-Wolf S, Maihöfner C, Enax-Krumova EK, et al. Can self-reported pain characteristics and bedside test be used for the assessment of pain mechanisms? An analysis of results of neuropathic pain questionnaires and quantitative sensory testing. Pain. 2019;160(9):2093-104.
13. Treviño M, Zhu X, Lu YY, Scheuer LS, Passell E, Huang GC, et al. How do we measure attention? Using factor analysis to establish construct validity of neuropsychological tests. Cognitive Research: Principles and Implications. 2021;6(1):1-26.
14. Westenberg RF, Nierich J, Lans J, Garg R, Eberlin KR, Chen NC. What factors are associated with response rates for long-term follow-up questionnaire studies in hand surgery? Clinical Orthopaedics and Related Research. 2020;478(12):2889.

Most read articles by the same author(s)